. "The Information Technology Aided Relapse Prevention Programme in Schizophrenia: an extension of a mirror-design follow-up"@en . "5"^^ . "Aims: Decreasing a number of hospital admissions is important for improving outcomes for people with schizophrenia. The Information Technology Aided Relapse Prevention Programme in Schizophrenia (ITAREPS) programme enables early pharmacological intervention in psychosis by identification of prodromal symptoms of relapse using home telemonitoring via a phone-to-PC SMS platform. Methods: This study was a 1-year extension of a previously published mirror-design followup evaluation of programme clinical effectiveness. In total, 73 patients with psychotic illness (45 patients from original sample and 28 newly added subjects) collaborating with 56 family members participated in the clinical evaluation. Results: There was a statistically significant 77% decrease in the number of hospitalisations during the mean 396.8 ? 249.4 days of participation in ITAREPS, compared with the same time period before participation in ITAREPS (Wilcoxonsigned ranks test, p < 0.00001), as well as significantly reduced number"@en . . . "8"^^ . . "RIV/00023752:_____/08:00000917!RIV09-MZ0-00023752" . "schizophrenia; psychotic disorders; relapse prevention; hospitalisations"@en . . "\u0160paniel, Filip" . . "4"^^ . "International Journal of Clinical Practice" . "GB - Spojen\u00E9 kr\u00E1lovstv\u00ED Velk\u00E9 Brit\u00E1nie a Severn\u00EDho Irska" . . "Hrdli\u010Dka, J." . . "The Information Technology Aided Relapse Prevention Programme in Schizophrenia: an extension of a mirror-design follow-up"@en . . "[14F6FEF5D49E]" . "Informa\u010Dn\u00EDmi technologiemi podporovan\u00FD program prevence relapsu psychotick\u00E9ho onemocn\u011Bn\u00ED: extenze zrcadlov\u011B uspo\u0159\u00E1dan\u00E9ho sledov\u00E1n\u00ED."@cs . "The Information Technology Aided Relapse Prevention Programme in Schizophrenia: an extension of a mirror-design follow-up" . "Informa\u010Dn\u00EDmi technologiemi podporovan\u00FD program prevence relapsu psychotick\u00E9ho onemocn\u011Bn\u00ED: extenze zrcadlov\u011B uspo\u0159\u00E1dan\u00E9ho sledov\u00E1n\u00ED."@cs . "The Information Technology Aided Relapse Prevention Programme in Schizophrenia: an extension of a mirror-design follow-up" . "12" . . . . . "1368-5031" . . . "Vohl\u00EDdka, P." . "\u010Cerm\u00E1k, Jan" . . "N, S, Z(MSM6840770012)" . "Ko\u017Een\u00FD, Ji\u0159\u00ED" . . "372435" . "62" . "Aims: Decreasing a number of hospital admissions is important for improving outcomes for people with schizophrenia. The Information Technology Aided Relapse Prevention Programme in Schizophrenia (ITAREPS) programme enables early pharmacological intervention in psychosis by identification of prodromal symptoms of relapse using home telemonitoring via a phone-to-PC SMS platform. Methods: This study was a 1-year extension of a previously published mirror-design followup evaluation of programme clinical effectiveness. In total, 73 patients with psychotic illness (45 patients from original sample and 28 newly added subjects) collaborating with 56 family members participated in the clinical evaluation. Results: There was a statistically significant 77% decrease in the number of hospitalisations during the mean 396.8 ? 249.4 days of participation in ITAREPS, compared with the same time period before participation in ITAREPS (Wilcoxonsigned ranks test, p < 0.00001), as well as significantly reduced number" . "H\u00F6schl, Cyril" . . "Motlov\u00E1, Lucie" . . "RIV/00023752:_____/08:00000917" . "Nov\u00E1k, Tom\u00E1\u0161" . . . . "C\u00EDl: Sn\u00ED\u017Een\u00ED po\u010Dtu psychiatrick\u00FDch hospitalizac\u00ED je d\u016Fle\u017Eit\u00FDm p\u0159edpokladem zlep\u0161en\u00ED dlouhodob\u00E9ho stavu pacient\u016F se schizofreni\u00ED. Information Technology Aided Relapse Prevention Programme in Schizophrenia (ITAREPS) umo\u017E\u0148uje \u010Dasnou farmakologickou intervenci u psychotick\u00FDch onemocn\u011Bn\u00ED pomoc\u00ED detekce prodrom\u00E1ln\u00EDch p\u0159\u00EDznak\u016F, a to s pou\u017Eit\u00EDm mobiln\u00EDch telefon\u016F a po\u010D\u00EDta\u010De. Metodika: tato studie je ro\u010Dn\u00ED extenz\u00ED p\u0159edchoz\u00EDho sledov\u00E1n\u00ED klinick\u00E9 \u00FA\u010Dinnosti programu. Celkem bylo do studie zahrnuto 73 pacient\u016F s psychotick\u00FDm onemocn\u011Bn\u00EDm ( 45 pacient\u016F z p\u016Fvodn\u00EDho souboru a 28 nov\u011B za\u0159azen\u00FDch subjekt\u016F), kte\u0159\u00ED spolupracovali s 56 rodinn\u00FDmi p\u0159\u00EDslu\u0161n\u00EDky. V\u00FDsledek: V porovn\u00E1n\u00ED s obdob\u00EDm p\u0159ed vstupem do programu ITAREPS byla zji\u0161t\u011Bna v dob\u011B \u00FA\u010Dasti v projektu celkem 77% redukce po\u010Dtu hospitalizac\u00ED b\u011Bhem pr\u016Fm\u011Brn\u00E9ho \u00FA\u010Dasti v programu v d\u00E9lce 396.8 ? 249.4 dn\u016F (Wilcoxon signed ranks test, p < 0.00001). Byla pozorov\u00E1na statisticky signifikantn\u00ED redukce v po\u010Dtu hospitaliza\u010Dn\u00EDch dn\u016F b\u011Bhem \u00FA\u010Dasti v programu (2365 hospital"@cs .